Cargando…
Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
Two-stage designs are commonly used for Phase II trials. Optimal two-stage designs have the lowest expected sample size for a specific treatment effect, for example, the null value, but can perform poorly if the true treatment effect differs. Here we introduce a design for continuous treatment respo...
Autores principales: | Wason, James M. S., Mander, Adrian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662082/ https://www.ncbi.nlm.nih.gov/pubmed/22651118 http://dx.doi.org/10.1080/10543406.2010.528104 |
Ejemplares similares
-
The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
por: Wason, James MS, et al.
Publicado: (2015) -
Blinded and unblinded sample size reestimation in crossover trials balanced for period
por: Grayling, Michael J., et al.
Publicado: (2018) -
Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2018) -
Optimal multistage designs for randomised clinical trials with continuous outcomes
por: Wason, James MS, et al.
Publicado: (2012) -
An adaptive trial design for updating the threshold of a continuous biomarker
por: Spencer, Amy, et al.
Publicado: (2015)